PharmaBoardroom

Francis Van Parys – President & CEO, GE Healthcare…

* This interview was conducted before GE’s announcement of its divestment of the GE Biopharma business Francis Van Parys, president & CEO of…

Woosok Lee – CEO, Kolon Life Science; Kolon TissueGene;…

Woosok Lee, CEO of Kolon Pharma, Kolon Life Science and Kolon TissueGene, offers his insights into the potential of their blockbuster product Invossa…

Hong Chow – General Manager, Roche Pharma China

Hong Chow, general manager of Roche Pharma China, shares Roche China’s incredible milestones over the past few years, including four pivotal…

Dominique Le Guludec – President, HAS, France

In an exclusive interview, Dominique Le Guludec, president of the French National Authority for Health (Haute Autorité de Santé (HAS)), offers her…

First Ever Biosimilar Approval in China: Trouble for Roche?

China’s regulator approved a biosimilar version of Roche’s Rituxan this week, the first such drug ever to be given the green light in the country.…

Top 10 Orphan Drugs in the USA

The Top 10 bestselling orphan drugs in the USA in 2017. Celgene's Revlimid (generic name lenolidamide) leads the way with sales of USD 5.4 billion,…

Top 10 Global Orphan Drug Companies Ranking 2017

The top 10 companies in the world ranked by global orphan drug sales and market share in 2017. Swiss giants Novartis and Roche take the top two…

Françoise Alliot-Launois – Vice President, AFLAR, France

Françoise Alliot-Launois, VP of the French League Against Rheumatism (AFLAR), discusses the issues around bone and joint infections in France,…

Sora Lee – Vice President & General Manager Korea,…

Syneos Health, established through a merger in 2017, has held a foothold in Korea through its legacy organisations for over 10 years. Sora Lee,…

Arnaud Gobet – President, Innothera, France

Arnaud Gobet, president of Innothera, discusses how the company balances its unique and diverse offering of medical devices, hygiene and protection…

Roche Fights off Biosimilar Competition to Grow 7% in 2018

Roche announced strong Group sales growth of seven percent for 2018, partly driven by the launch of MS blockbuster Ocrevus, which CEO Severin Schwan…

NEW Special Pharma Report on Algeria

Click here to download the Healthcare & Life Sciences Review Algeria 2019 report. Algeria, Africa’s largest country by area, stands…

Tagged with HE